Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01751672 · ClinicalTrials.gov registry record · NA
Integrating Substance Abuse Assessment & Intervention in Primary Care Settings
A NA study, sponsored by Treatment Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT01751672: Completed NA study, sponsored by Treatment Research Institute.
NCT01751672 is a NA study that has completed, run by Treatment Research Institute. The registered enrollment target is 600 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01751672, a NA study, has completed, sponsored by Treatment Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
The purposes of this study are to: 1) implement a high fidelity Screening, Brief Intervention and Referral to Treatment (SBIRT) protocol with computerized screening technology into three primary care clinics in urban Philadelphia; 2) conduct a randomized controlled trial to determine if an expanded SBIRT (SBIRT+) will help patients attend more specialty substance abuse treatment sessions and reduce substance use compared to SBIRT; 3) conduct a process evaluation of SBIRT+ at the three collaborating clinics consisting of focus groups and structured interviews to assess implementation barriers and workforce attitudinal shifts; and 4) provide an excellent clinical research training environment for undergraduate and graduate students from Lincoln University.
Primary Outcome
Treatment sessions attended for alcohol or drug use issues over time.
Interventions
- BEHAVIORAL SBIRT
- BEHAVIORAL SBIRT+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT01751672 record still lists
NCT01751672 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which SBIRT is the first listed.
NCT01751672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01751672 about?
NCT01751672 is a clinical study titled "Integrating Substance Abuse Assessment & Intervention in Primary Care Settings". The purposes of this study are to: 1) implement a high fidelity Screening, Brief Intervention and Referral to Treatment (SBIRT) protocol with computerized screening technology into three primary care clinics in urban Philadelphia; 2) conduct a randomized controlled trial to determine if an expanded ...
What is the current status of trial NCT01751672?
This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2012-06. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01751672?
The interventions under investigation include: SBIRT (BEHAVIORAL), SBIRT+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT01751672?
This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01751672's enrollment target sits among peer trials
600 162nd of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia